Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06605859

DigiDiab Pilot Spain - Nursing Home and Domiciliary Nursing Care

An Open, Multicentre, Prospective, Non-interventional Study of the CE-marked Medical Device GlucoTab in Nursing Homes and Domiciliary Nursing Care, According to Intended Use Without Additional Invasive and Stressful Measures

Status
Recruiting
Phase
Study type
Observational
Enrollment
40 (estimated)
Sponsor
Medical University of Graz · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

GlucoTab is a stand-alone software system to support healthcare professionals in the care of patients with diabetes mellitus or newly diagnosed hyperglycaemia who are treated with insulin and/or other glucose-lowering drugs or of patients only requiring glucose monitoring. It provides a therapy algorithm for subcutaneous basal insulin therapy of patients with type 2 diabetes, which will be used in this study.

Detailed description

GlucoTab: The CE-marked medical device GlucoTab is a system designed to support healthcare personnel in managing insulin therapy for patients with diabetes. In this study, only the GlucoTab algorithm supported basalinsulin therapy will be used, which is intended for patients with Type 2 diabetes in domiciliary nursing care and nursing homes requiring insulin therapy.

Conditions

Interventions

TypeNameDescription
DEVICEGlucoTabInsulin therapy will be started and adjusted according to the GlucoTab system with incorporated software algorithm. The goal of the basal-insulin algorithm is to maintain blood glucose within acceptable targets according to the predefined health status. For a limited time period after therapy start, three measurements per day are suggested by the algorithm to determine blood glucose. Insulin dosage titration will be performed according to the algorithm in GlucoTab under supervision of the nurses of the nursing homes/domiciliary nursing care. Correctional bolus insulin will be administered at defined time-points according to BG targets in the predefined health status. Nurses and nursing assistants will be trained in the use of the GlucoTab.
OTHERDiabetes TreatmentDiabetes Standard Care

Timeline

Start date
2025-04-08
Primary completion
2025-09-15
Completion
2025-09-15
First posted
2024-09-20
Last updated
2025-08-03

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT06605859. Inclusion in this directory is not an endorsement.